Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,02 USD | -1,31% | -0,66% | +9,03% |
28/03 | CELLECTAR BIOSCIENCES, INC. : Roth MKM handhaaft koopadvies | ZM |
28/03 | CELLECTAR BIOSCIENCES, INC. : Oppenheimer handhaaft koopadvies | ZM |
Omzet 2024 * | - | Omzet 2025 * | 44,27 mln. 41,26 mln. | Marktkapitalisatie | 97,43 mln. 90,8 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -49 mln. -45,67 mln. | Nettowinst (verlies) 2025 * | -22 mln. -20,5 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 2,2 x |
K/w-verhouding 2024 * |
-1,85
x | K/w-verhouding 2025 * |
-5,24
x | Werknemers | 20 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 88,18% |
Recentste transcriptie over Cellectar Biosciences, Inc.
1 dag | -1,31% | ||
1 week | -0,66% | ||
Lopende maand | -24,12% | ||
1 maand | -21,96% | ||
3 maanden | -15,88% | ||
6 maanden | +20,32% | ||
Lopend jaar | +9,03% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James V. Caruso
CEO | Chief Executive Officer | 65 | 15-06-15 |
Chad J. Kolean
DFI | Director of Finance/CFO | 59 | 28-05-14 |
Andrei Shustov
CTO | Chief Tech/Sci/R&D Officer | - | 15-02-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 07-04-17 |
Douglas Swirsky
CHM | Chairman | 54 | 07-04-17 |
John Neis
BRD | Director/Board Member | 68 | 01-02-08 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 3,02 | -1,31% | 690 802 |
24-04-24 | 3,06 | -1,61% | 1 043 212 |
23-04-24 | 3,11 | -2,51% | 899 197 |
22-04-24 | 3,19 | +5,28% | 866 660 |
19-04-24 | 3,03 | -0,33% | 806 967 |
uitgestelde koers Nasdaq, 25 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,03% | 97,43 mln. | |
+24,87% | 556 mld. | |
-6,33% | 354 mld. | |
+19,90% | 331 mld. | |
+7,95% | 296 mld. | |
+13,68% | 233 mld. | |
+5,67% | 201 mld. | |
-10,18% | 193 mld. | |
-12,26% | 143 mld. | |
-6,47% | 144 mld. |